Departments of Pharmacotherapy and Outcomes Science and Neurosurgery, Virginia Commonwealth University, Richmond, VA, USA.
Department of Clinical Pharmacy, Barnes-Jewish Hospital, Washington University in St. Louis, St. Louis, MO, USA.
Neurocrit Care. 2017 Sep;27(Suppl 1):51-73. doi: 10.1007/s12028-017-0456-x.
The appropriate use of medications during Emergency Neurological Life Support (ENLS) is essential to optimize patient care. Important considerations when choosing the appropriate agent include the patient's organ function and medication allergies, potential adverse drug effects, drug interactions and critical illness and aging pathophysiologic changes. Critical medications used during ENLS include hyperosmolar therapy, anticonvulsants, antithrombotics, anticoagulant reversal and hemostatic agents, anti-shivering agents, neuromuscular blockers, antihypertensive agents, sedatives, vasopressors and inotropes, and antimicrobials. This article focuses on the important pharmacokinetic and pharmacodynamics characteristics, advantages and disadvantages and clinical pearls of these therapies, providing practitioners with essential drug information to optimize pharmacotherapy in acutely ill neurocritical care patients.
在紧急神经生命支持(ENLS)期间使用药物是至关重要的,这可以优化患者的治疗效果。在选择合适的药物时,需要考虑患者的器官功能和药物过敏、潜在的药物不良反应、药物相互作用以及危重病和衰老的病理生理变化。在 ENLS 期间使用的关键药物包括高渗治疗、抗惊厥药、抗血栓药物、抗凝剂逆转和止血剂、止寒战药物、神经肌肉阻滞剂、降压药、镇静剂、血管加压药和正性肌力药以及抗菌药物。本文重点介绍了这些治疗方法的重要药代动力学和药效学特征、优缺点和临床要点,为临床医生提供了优化急性神经危重病患者药物治疗的基本药物信息。